GCR — Psyence Income Statement
0.000.00%
Last trade - 00:00- CA$40.49m
- CA$40.14m
Annual income statement for Psyence, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.51 | 6.01 | 63.1 | 6.06 | 1.16 |
| Operating Profit | -4.51 | -6.01 | -63.1 | -6.06 | -1.16 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.6 | -6.08 | -69.4 | -0.03 | -1.39 |
| Net Income After Taxes | -4.6 | -6.08 | -69.4 | -0.03 | -1.39 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.6 | -6.08 | -69.4 | -0.4 | -0.586 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.6 | -6.08 | -69.4 | -0.4 | -0.586 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.61 | -7.07 | -9.06 | 0.109 | -0.134 |